News

In the news section, our experts take center stage in shaping discussions on technology and policy. Discover articles featuring insights from our experts or citing our research. CSET’s insights and research are pivotal in shaping key conversations within the evolving landscape of emerging technology and policy.

Dewey Murdick and Miriam Vogel shared their expert analysis in an op-ed published by Fortune. In their piece, they highlight the urgent need for the United States to strengthen its AI literacy and incident reporting systems to maintain global leadership amid rapidly advancing international competition, especially from China’s booming AI sector.

Assessment


China


Filter entries

CSET’s Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by the Bulletin of the Atomic Scientists. The article discusses how rapidly advancing biotechnology and AI are reshaping biosecurity, highlighting both the promise of new scientific tools and the need for stronger, adaptive safeguards.

Federal Funding Cuts Threaten US Biosafety

The National Interest
| September 3, 2025

CSET’s Steph Batalis shared her expert analysis in an op-ed published by The National Interest. In her piece, she discusses how proposed federal research funding cuts threaten not only U.S. scientific progress but also the safety and security of biological research. These cuts would weaken the safeguards, oversight, and resources that protect both scientists and the public from accidents and biological threats.

Will Trump’s ‘Big Beautiful’ Defense Spending Last?

Council on Foreign Relations
| July 9, 2025

Lauren A. Kahn co-authored an op-ed published by the Council on Foreign Relations alongside Erin D. Dumbacher and Michael C. Horowitz. The piece examines the sweeping national security implications of President Trump’s One, Big Beautiful Bill Act, which significantly boosts U.S. defense spending through an unconventional funding route outside the standard Pentagon budget process.

CSET's Steph Batalis shared her expert analysis in an op-ed published by DefenseOne. In her piece, she highlights how the United States’ faltering response to the ongoing measles outbreak reveals serious vulnerabilities in the nation’s public health and biodefense infrastructure.

Trump Should Not Abandon March-In Rights

The National Interest
| April 25, 2025

Jack Corrigan and Vikram Venkatram shared their expert analysis in an op-ed published by The National Interest. In their piece, they examine the political and legal controversy surrounding the Biden administration’s draft guidance on “march-in rights” under the Bayh-Dole Act, which could allow federal agencies to lower drug prices by reclaiming patents on taxpayer-funded inventions when they are not reasonably accessible to the public.

How to stop bioterrorists from buying dangerous DNA

Bulletin of the Atomic Scientists
| April 7, 2025

CSET's Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by The Bulletin of the Atomic Scientists. The article explores discusses the complexities and challenges of screening DNA synthesis orders to prevent misuse of potentially dangerous genetic sequences.

In an article published by The Japan Times that discusses the White House’s push for the Pentagon and U.S. national security agencies to accelerate the adoption of AI technology, CSET Research Fellow, Sam Bresnick, provided his expert insights.

In an article published by Axios that discusses how AI-driven "biosurveillance" could be instrumental in detecting future pandemics or biological attacks, CSET's Steph Batalis provided her expert insights.

In an article published by WIRED exploring China's advancement in BCI technology, CSET's William Hannas offered his expert insight.

“AI Chips: What They Are and Why They Matter,“ a report by CSET, was referenced in a Business Insider article. The article explores the urgent need in the US for more workers skilled in building AI chips. It highlights a significant decline in the American semiconductor workforce over the past two decades.